Showing results (61-70 of 2,686) with videos related to

Sort By:
Pageof 269
The Lancet. Infectious Diseases|December 24, 2013
Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in actionCharlotte I S Barker, Matthew D Snape
The Lancet. Infectious Diseases|July 8, 2014
Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trialHector H Garcia, Isidro Gonzales, Andres G Lescano, et al.
The Lancet. Infectious Diseases|November 26, 2013
Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trialAlicia M Fry, Doli Goswami, Kamrun Nahar, et al.
The Lancet. Infectious Diseases|May 21, 2016
Viraemia and Ebola virus secretion in survivors of Ebola virus disease in Sierra Leone: a cross-sectional cohort studyEdward Green, Luke Hunt, J C Gareth Ross, et al.
The Lancet. Infectious Diseases|April 4, 2016
The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic studyJeffrey B Joy, Rosemary M McCloskey, Thuy Nguyen, et al.
The Lancet. Infectious Diseases|July 13, 2016
Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniaeBonnie C Prokesch, Michael TeKippe, Jiwoong Kim, et al.
The Lancet. Infectious Diseases|August 5, 2017
Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancerA L Colombo, J N de Almeida Júnior, Monica A Slavin, et al.
The Lancet. Infectious Diseases|June 15, 2016
Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trialMichael Schwameis, Bernhard Roppenser, Christa Firbas, et al.
The Lancet. Infectious Diseases|June 13, 2016
Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosisJennifer Ho, Phuong Thi Bich Nguyen, Thu Anh Nguyen, et al.
The Lancet. Infectious Diseases|September 3, 2017
Efficacy and safety of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel pamoate, and albendazole plus oxantel pamoate against hookworm and concomitant soil-transmitted helminth infections in Tanzania and Côte d'Ivoire: a randomised, controlled, single-blinded, non-inferiority trialWendelin Moser, Jean T Coulibaly, Said M Ali, et al.
Pageof 269